Helping veterans, battling opioid addiction driving magic mushroom legislation progress

Forty lawmakers, 36 Democrats and 4 Republicans, have co-sponsored a bill aiming to allow for the medical use of psilocybin and a psilocybin therapy grant program, which is currently sitting at the committee level of the Assembly, with its Senate version also in committee. The Assembly bill, A03581, was introduced by Democrat Pat Burke in February. There has been other legislation introduced regarding the hallucinogen as well, with Linda Rosenthal’s version legalizing the adult possession and use of hallucinogens like it.

Research has shown that psilocybin, an organic psychedelic compound, can benefit people with cluster headaches, depression, anxiety, irritable bowel syndrome, ADHD and obsessive compulsive disorder, but it’s getting the most universal traction because of its impact on those suffering from PTSD.

“Psilocybin doesn’t have the huge appeal that marijuana had,” Democrat Assemblyman Phil Steck, who is the Assembly’s Chairman of the Alcoholism and Drug Abuse Committee, says. “But, there are definitely people who make a strong case for the proposition that it helps with PTSD. Certainly we want to do everything that we can to help people that are coming back from war, and if psilocybin has proven to do that, then it should be legal for that purpose.”

Johns Hopkins University has conducted several studies on psilocybin, saying it has substantial antidepressant effects, but needs to be administered under carefully controlled conditions through trained clinicians and therapists.

Keep reading

Prohibition Gave Us Xylazine in Fentanyl. The Solution, Drug Warriors Say, Is More Prohibition.

The emergence of the animal tranquilizer xylazine as a fentanyl adulterant, like the emergence of fentanyl as a heroin booster and substitute, has prompted law enforcement officials to agitate for new legal restrictions and criminal penalties. That response is fundamentally misguided, because the threat it aims to address is a familiar consequence of prohibition, which creates a black market in which drug composition is highly variable and unpredictable. Instead of recognizing their complicity in maintaining and magnifying that hazard, drug warriors always think the answer is more of the same.

Xylazine was first identified as a fentanyl adulterant in 2006, and today it is especially common in Puerto Rico, Philadelphia, Maryland, and Connecticut. In Philadelphia between 2010 and 2015, according to a 2021 BMJ article, xylazine was detected in less than 2 percent of drug-related deaths involving heroin and/or fentanyl. Its prevalence in such cases had risen to 31 percent by 2019. According to a 2022 Cureus report, “up to 78%” of illicit fentanyl sold in Puerto Rico and Philadelphia contains xylazine. In 2022, the Drug Enforcement Administration (DEA) reports, xylazine was detected in 23 percent of fentanyl powder and 7 percent of fentanyl pills analyzed by its laboratories.

Xylazine is a sedative, analgesic, and muscle relaxant that is not approved for use in humans but is commonly used by veterinarians. It is chemically similar to phenothiazines, tricyclic antidepressants, and clonidine. But like fentanyl and other opioids, xylazine depresses respiration, so combining it with narcotics can increase the risk of a fatal reaction. Unlike a fentanyl overdose, a xylazine overdose cannot be reversed by the opioid antagonist naloxone.

Xylazine also seems to increase the risk of potentially serious skin infections and ulcers that have always been a hazard of unsanitary injection practices. According to a 2022 article in Dermatology World Insights and Inquiries, “the presumed mechanism” is “the direct vasoconstricting effect on local blood vessels and resultant decreased skin perfusion,” which impairs healing.

Why is xylazine showing up in fentanyl? For the same reasons fentanyl started showing up in heroin. As a 2014 literature review in Forensic Science International notes, “illicit drugs, such as cocaine and heroin, are often adulterated with other agents to increase bulk and enhance or mimic the illicit drug’s effects.” Because xylazine and heroin have “some similar pharmacologic effects,” the authors say, “synergistic effects may occur in humans when xylazine is use as an adulterant of heroin.”

Keep reading

GOP embraces a new foreign policy: Bomb Mexico to stop fentanyl

A growing number of prominent Republicans are rallying around the idea that to solve the fentanyl crisis, America must bomb it away.

In recent weeks, Donald Trump has discussed sending “special forces” and using “cyber warfare” to target cartel leaders if he’s reelected president and, per Rolling Stone, asked for “battle plans” to strike Mexico. Reps. Dan Crenshaw (R-Texas) and Mike Waltz (R-Fla.) introduced a bill seeking authorization for the use of military force to “put us at war with the cartels.” Sen. Tom Cotton (R-Ark.) said he is open to sending U.S. troops into Mexico to target drug lords even without that nation’s permission. And lawmakers in both chambers have filed legislation to label some cartels as foreign terrorist organizations, a move supported by GOP presidential aspirants.

“We need to start thinking about these groups more like ISIS than we do the mafia,” Waltz, a former Green Beret, said in a short interview.

Not all Republican leaders are behind this approach. John Bolton, Trump’s third national security adviser who’s weighing his own presidential run, said unilateral military operations “are not going to solve the problem.” And House Foreign Affairs Committee Chair Mike McCaul (R-Texas), for example, is “still evaluating” the AUMF proposal “but has concerns about the immigration implications and the bilateral relationship with Mexico,” per a Republican staff member on the panel.

But the eagerness of some Republicans to openly legislate or embrace the use of the military in Mexico suggests that the idea is taking firmer root inside the party. And it illustrates the ways in which frustration with immigration, drug overdose deaths and antipathy towards China are defining the GOP’s larger foreign policy.

Keep reading

Secret limits to stop ‘suspicious’ Xanax and Adderall orders are forcing some legitimate patients to scramble

Patients diagnosed with conditions like anxiety and sleep disorders have become caught in the crosshairs of America’s opioid crisis, as secret policies mandated by a national opioid settlement have turned filling legitimate prescriptions into a major headache.

In July, limits went into effect that flag and sometimes block pharmacies’ orders of controlled substances such as Adderall and Xanax when they exceed a certain threshold. The requirement stems from a 2021 settlement with the US’s three largest drug distributors — AmerisourceBergen Corp., Cardinal Health Inc. and McKesson Corp. But pharmacists said it curtails their ability to fill prescriptions for many different types of controlled substances — not just opioids.

Independent pharmacists said the rules force them come up with creative workarounds. Sometimes, they must send patients on frustrating journeys to find pharmacies that haven’t yet exceeded their caps in order to buy prescribed medicines.

“I understand the intention of this policy is to have control of controlled substances so they don’t get abused, but it’s not working,” said Richard Glotzer, an independent pharmacist in Millwood, New York. “There’s no reason I should be cut off from ordering these products to dispense to my legitimate patients that need it.”

It’s unclear how the thresholds are impacting major chain pharmacies. CVS Health Corp. didn’t provide comment. A spokesperson for Walgreens Boots Alliance Inc. said its pharmacists “work to resolve any specific issues when possible, in coordination with our distributors.” 

Keep reading

“Grandma of the Police Officers Association” in California Arrested for Importing Fentanyl From China and Other Countries

As the drug crisis in America rages on as opioids and fentanyl pour across our unsecured border from the Mexican drug cartels supplied by Chinese “pharmaceuticals,” an unsuspecting trafficker has emerged.

San Jose Police Officers Association police union executive Joanne Marian Segovia was arrested on Wednesday for attempting to import a synthetic opioid called Valeryl fentanyl.  If convicted, she faces up to 20 years in federal prison.

Police union president Sean Pritchard told the New York Post that Segovia was like “the grandma of the POA…this is not the person we’ve known, the person who has worked with fallen officers’ families, organized fundraisers for officers’ kids…”

Segovia was allegedly importing packages of drugs from China, Canada, India and other countries and disguising them as common items such as makeup, chocolates, and food supplements.  She has received at least 61 packages at her home from 2015 through 2023.

Keep reading

Abrupt closure of ketamine clinic chain blindsides veterans and others with severe depression and chronic pain

Military veterans across the country are scrambling after more than a dozen clinics that had been providing them with free ketamine treatments for severe depression, chronic pain or post-traumatic stress disorder suddenly closed.

Patients and employees of the Ketamine Wellness Centers, or KWC, said they were blindsided when the company, one of the nation’s largest operators of ketamine clinics, announced on its website on March 10 that it had shuttered all 13 of its locations in nine states.

“I cried for days,” said Travis Zubick, a U.S. Navy veteran, who was a patient at the company’s Minnesota location. “They packed up and left town, and that’s over.”

Zubick and about 50 other former service members had been relying on KWC’s partnership with the U.S. Department of Veterans Affairs for free ketamine treatments.

Now, many are rushing to find another facility that takes their VA insurance before the effects of their last treatment wear off.

Keep reading

Hospitals Are Still Reporting New Mothers for Neglect Based on Drug Tests Triggered by Poppy Seeds

Before Kate L. gave birth to a baby girl last September, a nurse at New Jersey’s Hackensack University Medical Center collected a urine sample from the soon-to-be mother. Kate thought nothing of it, because she was accustomed to having her urine tested for protein levels during her pregnancy. She had no idea that her urine would be tested for drugs, which resulted in a terrifying, monthslong investigation aimed at determining if she was a fit mother.

Kaitlin K. had a similar experience when she gave birth to a baby boy at Virtua Voorhees Hospital in Camden County, New Jersey, the following month. The immediate culprit in both cases seems to have been a poppy seed bagel that triggered a false positive for opiates. That, in turn, led to state investigations of alleged child neglect. But the real blame, according to complaints filed this month by the American Civil Liberties Union (ACLU) of New Jersey, lies with the hospitals, which it says conducted nonconsensual, medically unnecessary, and woefully inadequate drug tests, then reported the erroneous results to the New Jersey Department of Child Protection and Permanency (DCPP).

The ACLU, which is asking the New Jersey Department of Law and Public Safety’s  Division on Civil Rights to stop that practice and award compensatory damages, argues that a policy of “drug testing perinatal patients on the basis of sex and pregnancy” constitutes illegal discrimination under state law. Whatever the legal merits of that claim, the sneaky, arbitrary, high-handed, and cruel treatment described in the complaints shows what can happen when medical personnel forsake their ethical responsibilities in service of the war on drugs.

“No one should be subjected to unnecessary and nonconsensual drug tests,” says ACLU of New Jersey staff attorney Molly Linhorst. “Our clients are sending a clear message to hospitals that these testing and reporting policies are unacceptable. Discriminatory testing policies like these upend what should be a time of joy for families, and so often subject them to further trauma and unwarranted investigation by the state.”

Keep reading

Priorities: Defense Dept. Holds Diversity, Equity, and Inclusion “Summit” As Military Fentanyl Overdoses Surge

In an article entitled “‘You Can’t Fix the Problem If You’re in Denial:’ The Military’s Surge of Fentanyl Overdoses,” Military.com tells the story of Carole De Nola, whose son Ari McGuire, “a 23-year-old reconnaissance scout with Fort Bragg’s storied 82nd Airborne Division,” died of a fentanyl overdose.

[O]n a Friday night in August 2019, De Nola got a call from an Army officer: Her son was on life support in a Fayetteville, North Carolina, hospital. Ari’s heart had stopped beating while riding in an Uber, coming through the gate at Fort Bragg. An ambulance had managed to revive him, and Ari was induced into a coma upon arriving at the hospital.

De Nola, her husband Joseph, and the cantor from their synagogue had made the daylong trek from California to North Carolina to say goodbye to Ari. “When we got there, the doctor told us that there was nothing they could do. I’m sure that the whole hospital heard me screaming.”

Unfortunately, statistics show that Ari is not alone. His death was one of 332 fatal overdoses within the military, according to information newly released by the Pentagon on ODs between 2017 and 2021. That five-year period also saw 15,000 non-fatal ODs among the active-duty force. Fort Bragg is a known drug “hot spot“; “Thirty-four soldiers died at the base between 2017 and 2021; it also saw a 100% increase in drug crime over 2021. Those deaths account for more than 10% of the total fatalities reported by the military.”

Gil Cisneros, the Under Secretary of Defense for Personnel and Readiness, stated in a letter accompanying the new fentanyl statistics that “[w]e share your concern that drug overdose is a serious problem and must be addressed.” But “De Nola said that she doesn’t feel that the military has done enough.” Others agree.

Alex Bennett, a professor at NYU’s School of Public Health who has led several studies addressing opioid-use among military veterans, stated that “what we have in the military is sort of an epidemic that’s not fully acknowledged.”

Keep reading

Pentagon Finally Stops Hiding Military Overdose Epidemic

THE U.S. ARMY Special Forces, better known as the Green Berets, has a serious problem with substance abuse and fatal drug overdoses. The same is true of the Army’s two most important infantry divisions: the 101st Airborne Division and the 82nd Airborne Division.

That’s the takeaway of data released by the Pentagon this week to a group of five U.S. senators, led by Massachusetts Sen. Edward Markey. Markey, Massachusetts Sen. Elizabeth Warren, and others grew concerned about rising drug use in the military after reading a report in the September issue of Rolling Stone that at least 14 and as many as 30 American soldiers had died in 2020 and 2021 of overdoses at Fort Bragg, North Carolina. Fort Bragg is the headquarters of the Special Forces, as well as the top-secret Joint Special Operations Command, the “black ops” component of the military.

The senators wrote a letter to Secretary of Defense Lloyd Austin in late September requesting detailed statistics, going back five years, on accidental overdoses in the ranks. “We share your concern that drug overdose is a serious problem,” the Pentagon’s undersecretary for personnel and readiness wrote in response this week. “We must work to do better.”

A total of 15,293 American soldiers, sailors, airmen, and Marines overdosed on illicit drugs from 2017 to 2022, according to a compendium of data and analysis enclosed with the letter. Of those, 332 cases were fatal.

Consistent with Rolling Stone’s recent reporting, the data showed a rising long-term trend, followed by a sharp spike in overdose deaths among active-duty military men in 2020 and 2021. Fentanyl was by far the biggest killer, accounting for more than half of the casualties. “The number of OD deaths involving fentanyl has more than doubled over the past five years,” the Pentagon disclosed.

“With hundreds of fatal overdoses reported on U.S. military bases in recent years,” Markey writes in a statement to Rolling Stone, “the toll is mounting. We can and must curb this tragic trend.”

Keep reading

BC decriminalizes hard drugs amid fentanyl crisis

On Tuesday, following the granting of a three-year exemption from Health Canada, British Columbia became the first province in Canada to decriminalize hard drugs, with the government arguing that “substance use is a public health matter, not a criminal justice issue.”

Many have argued that it will only result in more drugs on the street and, inevitably, more dead British Columbians, while some have praised the move as a step in the right direction.

Under the new laws, adults found possessing less than 2.5 grams of certain formerly-illicit drugs will not face criminal charges, nor will they have the substances seized by law enforcement.

Drugs that can now be possessed and used without punishment include opioids, such as heroin, morphine, fentanyl, crack and powder cocaine, meth, and MDMA. 

The BC government emphasized that “decriminalization is not legalization,” noting that, “under this exemption, illegal drugs (including those listed above) are not legalized and will not be sold in stores. Drug trafficking remains illegal, regardless of the amount of drug(s) in possession.” They added that all prior restrictions relating to drug use at schools, airports, and private establishments will remain in place.

While the aforementioned drugs may not be sold in stores, in Vancouver, opioids were recently made available for purchase via vending machines. The project was meant to give users access to safe medical-grade opioids instead of potentially contaminated street drugs, however, it has come under scrutiny as of late due to the potential of misuse.

Keep reading